Exact Mass: 262.1448

Exact Mass Matches: 262.1448

Found 120 metabolites which its exact mass value is equals to given mass value 262.1448, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

streptidine

SCHEMBL6302605

C8H18N6O4 (262.1389)

An amino cyclitol that is scyllo-inositol in which the hydroxy groups at positions 1 and 3 are replaced by guanidino groups.

Etoglucid

2-[2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxy]ethoxymethyl]oxirane

C12H22O6 (262.1416)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AG - Epoxides C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents D000970 - Antineoplastic Agents

Alnustone

InChI=1/C19H18O/c20-19(16-15-18-11-5-2-6-12-18)14-8-7-13-17-9-3-1-4-10-17/h1-14H,15-16H2/b13-7+,14-8

C19H18O (262.1358)

Alnustone belongs to the class of organic compounds known as linear diarylheptanoids. These are diarylheptanoids with an open heptane chain. Alnustone is found in herbs and spices. Alnustone is a constituent of Curcuma xanthorrhiza (Java turmeric). Alnustone is a diarylheptanoid. Alnustone is a natural product found in Alnus pendula, Alpinia hainanensis, and other organisms with data available. Alnustone, a non-phenolic diarylheptanoid found in herbs and spices, is a constituent of Alpiniae Katsumada. Alnustone displays anti-emetic and anti-inflammatory activities[1][2]. Alnustone, a non-phenolic diarylheptanoid found in herbs and spices, is a constituent of Alpiniae Katsumada. Alnustone displays anti-emetic and anti-inflammatory activities[1][2].

Isoleucyl-Methionine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-4-(methylsulphanyl)butanoic acid

C11H22N2O3S (262.1351)

Isoleucyl-Methionine is a dipeptide composed of isoleucine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Methionyl-Isoleucine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-3-methylpentanoic acid

C11H22N2O3S (262.1351)

Methionyl-Isoleucine is a dipeptide composed of methionine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Leucyl-Methionine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-4-(methylsulphanyl)butanoic acid

C11H22N2O3S (262.1351)

Leucyl-Methionine is a dipeptide composed of leucine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Methionyl-Leucine

2-{[2-amino-1-hydroxy-4-(methylsulphanyl)butylidene]amino}-4-methylpentanoic acid

C11H22N2O3S (262.1351)

Methionyl-Leucine is a dipeptide composed of methionine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Phaseolic acid

5,8(9),12-Trihydroxy-2-oxododecanoic acid

C12H22O6 (262.1416)

Phaseolic acid is found in pulses. Phaseolic acid is isolated from dry bean seeds (Phaseolus sp. Isolated from dry bean seeds (Phaseolus species). Phaseolic acid is found in pulses.

4-Amino-3-hydroxybutanoylcarnitine

3-[(4-amino-3-hydroxybutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C11H22N2O5 (262.1529)

4-Amino-3-hydroxybutanoylcarnitine is an acylcarnitine. More specifically, it is an 4-amino-3-hydroxybutanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Amino-3-hydroxybutanoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 4-Amino-3-hydroxybutanoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

Cibenzoline

2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole

C18H18N2 (262.147)

C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Streptidine

N-(3-carbamimidamido-2,4,5,6-tetrahydroxycyclohexyl)guanidine

C8H18N6O4 (262.1389)

(E)-2-Hexenyl Beta-D-Glucopyranoside|(E)-2-hexenyl beta-D-glucoside|(E)-2-hexenyl-beta-D-glucopyranoside|(E)-2-Hexenyl-??-D-glucopyranoside|erigeside B

C12H22O6 (262.1416)

C12H22O6_beta-D-Glucopyranoside, (3Z)-3-hexen-1-yl

NCGC00380275-01_C12H22O6_beta-D-Glucopyranoside, (3Z)-3-hexen-1-yl

C12H22O6 (262.1416)

9-(2,3-dihydroxypropoxy)-9-oxononanoic acid

C12H22O6 (262.1416)

(2R,3R,4S,5S,6R)-2-[(Z)-hex-3-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C12H22O6 (262.1416)

1COOH-2But-A7EO1-OCH2COOH

C12H22O6 (262.1416)

Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); Could be alkyl homologue of given structure; Digitised from figure: approximate intensities

9-(2,3-dihydroxypropoxy)-9-oxononanoic acid_minor

C12H22O6 (262.1416)

9-(2,3-dihydroxypropoxy)-9-oxononanoic acid_major

C12H22O6 (262.1416)

(2R,3R,4S,5S,6R)-2-[(Z)-hex-3-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

C12H22O6 (262.1416)

Met Leu

C11H22N2O3S1 (262.1351)

Leu Met

C11H22N2O3S1 (262.1351)

Met Ile

C11H22N2O3S1 (262.1351)

Ile Met

C11H22N2O3S1 (262.1351)

Ile-met

2-[2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C11H22N2O3S (262.1351)

A dipeptide formed from L-isoleucine and L-methionine residues.

Leu-met

2-[2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C11H22N2O3S (262.1351)

A dipeptide formed from L-leucine and L-methionine residues.

Met-ile

2-(2-amino-3-methylpentanamido)-4-(methylsulfanyl)butanoic acid

C11H22N2O3S (262.1351)

A dipeptide formed from L-methionine and L-isoleucine residues.

Met-Leu

(S)-2-((S)-2-Amino-4-(methylthio)butanamido)-4-methylpentanoic acid

C11H22N2O3S (262.1351)

A dipeptide formed from L-methionine and L-leucine residues.

Alnusone

(4Z,6E)-1,7-diphenylhepta-4,6-dien-3-one

C19H18O (262.1358)

Alnustone, a non-phenolic diarylheptanoid found in herbs and spices, is a constituent of Alpiniae Katsumada. Alnustone displays anti-emetic and anti-inflammatory activities[1][2]. Alnustone, a non-phenolic diarylheptanoid found in herbs and spices, is a constituent of Alpiniae Katsumada. Alnustone displays anti-emetic and anti-inflammatory activities[1][2].

Phaseolic acid

2-oxo-5,8,12-trihydroxy-dodecanoic acid

C12H22O6 (262.1416)

ascr#12

5R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-hexanoic acid

C12H22O6 (262.1416)

An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (5R)-5-hydroxyhexanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematodes Caenorhabditis elegans and Pristionchus pacificus.

oscr#12

6-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-hexanoic acid

C12H22O6 (262.1416)

An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 6-hydroxyhexanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.